Sangamo BioSciences | Salg Og Administrasjonskostnader

Selling And Administration Expenses Endring Dato
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Avrobio USD 6.26M 1.68M 2023-09
Bayer EUR 3.6B 81M 2023-09
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Cipla INR 10.91B 245.2M 2023-09
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.29M 163K 2023-09
CSL USD 1.29B 219.4M 2023-06
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Grifols EUR 300.32M 28.7M 2023-09
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Merck USD 2.75B 272M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Sangamo BioSciences Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.